414 related articles for article (PubMed ID: 31208350)
1. Retinal function determined by flicker ERGs before and soon after intravitreal injection of anti-VEGF agents.
Terauchi G; Shinoda K; Sakai H; Kawashima M; Matsumoto CS; Mizota A; Miyake Y
BMC Ophthalmol; 2019 Jun; 19(1):129. PubMed ID: 31208350
[TBL] [Abstract][Full Text] [Related]
2. Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion.
Yasuda S; Kachi S; Ueno S; Piao CH; Terasaki H
Acta Ophthalmol; 2015 Sep; 93(6):e465-8. PubMed ID: 25597703
[TBL] [Abstract][Full Text] [Related]
3. Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV.
Wecker T; Ehlken C; Bühler A; Lange C; Agostini H; Böhringer D; Stahl A
Br J Ophthalmol; 2017 Mar; 101(3):353-359. PubMed ID: 27215744
[TBL] [Abstract][Full Text] [Related]
4. Long-term dynamic changes and influencing factors of corneal morphology after multiple intravitreal injections of anti-VEGF drugs.
Qi Y; Li C; Ye S; Zhang Z; Li S; Zhang L
Medicine (Baltimore); 2024 Apr; 103(17):e37937. PubMed ID: 38669379
[TBL] [Abstract][Full Text] [Related]
5. Assessment of patient pain experience during intravitreal 27-gauge bevacizumab and 30-gauge ranibizumab injection.
Güler M; Bilgin B; Çapkın M; Şimşek A; Bilak Ş
Korean J Ophthalmol; 2015 Jun; 29(3):190-4. PubMed ID: 26028948
[TBL] [Abstract][Full Text] [Related]
6. Changes of focal macular and full-field electroretinograms after intravitreal aflibercept in patients with central retinal vein occlusion.
Nishimura T; Machida S; Hara Y
Doc Ophthalmol; 2020 Oct; 141(2):169-179. PubMed ID: 32215778
[TBL] [Abstract][Full Text] [Related]
7. Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab.
Baget-Bernaldiz M; Romero-Aroca P; Bautista-Perez A; Mercado J
Doc Ophthalmol; 2017 Oct; 135(2):85-96. PubMed ID: 28779336
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional assessment after intravitreal injection of ranibizumab in diabetic macular edema.
Fu Y; Wang P; Meng X; Du Z; Wang D
Doc Ophthalmol; 2017 Dec; 135(3):165-173. PubMed ID: 28756595
[TBL] [Abstract][Full Text] [Related]
9. Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.
Saishin Y; Ito Y; Fujikawa M; Sawada T; Ohji M
Jpn J Ophthalmol; 2017 Jan; 61(1):67-73. PubMed ID: 27660163
[TBL] [Abstract][Full Text] [Related]
10. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases.
Ou WC; Brown DM; Payne JF; Wykoff CC
Am J Ophthalmol; 2017 Aug; 180():8-17. PubMed ID: 28549848
[TBL] [Abstract][Full Text] [Related]
12. Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion.
Nishimura T; Machida S; Tada A; Oshida E; Muto T
Doc Ophthalmol; 2019 Aug; 139(1):67-74. PubMed ID: 30980231
[TBL] [Abstract][Full Text] [Related]
13. Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion: 12-month results.
Nishimura T; Machida S; Tada A; Oshida E; Muto T
Doc Ophthalmol; 2020 Oct; 141(2):127-136. PubMed ID: 32100140
[TBL] [Abstract][Full Text] [Related]
14. Peripheral retinal function assessed with 30-Hz flicker seems to improve after treatment with Lucentis in patients with diabetic macular oedema.
Holm K; Schroeder M; Lövestam Adrian M
Doc Ophthalmol; 2015 Aug; 131(1):43-51. PubMed ID: 25773362
[TBL] [Abstract][Full Text] [Related]
15. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).
Wu L; Martínez-Castellanos MA; Quiroz-Mercado H; Arevalo JF; Berrocal MH; Farah ME; Maia M; Roca JA; Rodriguez FJ;
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):81-7. PubMed ID: 17674014
[TBL] [Abstract][Full Text] [Related]
16. Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Tsao YC; Chen TY; Wang LA; Lee CC; Lee WA; Hsu SM; Lai CC; Shao SC; Hung JH; Lai EC
BioDrugs; 2023 Nov; 37(6):843-854. PubMed ID: 37676536
[TBL] [Abstract][Full Text] [Related]
17. The effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusion.
Lehmann-Clarke L; Dirani A; Mantel I; Ambresin A
Klin Monbl Augenheilkd; 2015 Apr; 232(4):552-5. PubMed ID: 25902119
[TBL] [Abstract][Full Text] [Related]
18. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning Can Predict Anti-VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema.
Gallardo M; Munk MR; Kurmann T; De Zanet S; Mosinska A; Karagoz IK; Zinkernagel MS; Wolf S; Sznitman R
Ophthalmol Retina; 2021 Jul; 5(7):604-624. PubMed ID: 33971352
[TBL] [Abstract][Full Text] [Related]
20. The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment.
Nowacka B; Kirkiewicz M; Mozolewska-Piotrowska K; Lubiński W
Doc Ophthalmol; 2016 Apr; 132(2):111-22. PubMed ID: 27000269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]